Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia
暂无分享,去创建一个
T. Vulliamy | M. Gilleece | D. Bowen | R. Beswick | S. Schonland | I. Dokal | P. Hillmen | R. Kelly | A. Marrone | A. Walne | A. Whittle | M. Kirwan | Andrew Stewart | A. McVerry
[1] P. Rosenberg,et al. Cancer in dyskeratosis congenita. , 2009, Blood.
[2] A. Baruchel,et al. High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder. , 2009, Blood.
[3] E. Estey,et al. Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia , 2009, Proceedings of the National Academy of Sciences.
[4] J. Ivanovich,et al. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. , 2009, Blood.
[5] T. Pabst,et al. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] H. Tamary,et al. Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations , 2008, Haematologica.
[7] H. Ly,et al. Identification and functional characterization of novel telomerase variant alleles in Japanese patients with bone-marrow failure syndromes. , 2008, Blood cells, molecules & diseases.
[8] J. Fitzgibbon,et al. Familial myelodysplasia and acute myeloid leukaemia – a review , 2007, British journal of haematology.
[9] 邓伟平,et al. Dyskeratosis congenita , 2007 .
[10] S. Chanock,et al. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. , 2007, Blood.
[11] T. Vulliamy,et al. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations. , 2007, Haematologica.
[12] Chao Xing,et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase , 2007, Proceedings of the National Academy of Sciences.
[13] P. Lansdorp,et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.
[14] Yuying Liang,et al. Functional characterization of natural telomerase mutations found in patients with hematologic disorders. , 2007, Blood.
[15] M. McLellan,et al. Low Frequency of Telomerase RNA Mutations Among Children With Aplastic Anemia or Myelodysplastic Syndrome , 2006, Journal of pediatric hematology/oncology.
[16] I. Dokal,et al. Dyskeratosis congenita: a disorder of telomerase deficiency and its relationship to other diseases , 2006 .
[17] T. Vulliamy,et al. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. , 2006, Blood.
[18] T. Pabst,et al. C/EBPα and the pathophysiology of acute myeloid leukemia , 2006, Current opinion in hematology.
[19] H. Harada,et al. Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndrome. , 2005, Critical reviews in eukaryotic gene expression.
[20] Yen-Pei Christy Chang,et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[21] T. Vulliamy,et al. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. , 2005, Blood cells, molecules & diseases.
[22] S. Chanock,et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. , 2005, The New England journal of medicine.
[23] P. Lansdorp,et al. Functional characterization of telomerase RNA variants found in patients with hematologic disorders. , 2005, Blood.
[24] S. Kulkarni,et al. Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita. , 2005, Blood.
[25] T. Vulliamy,et al. Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency. , 2004, Blood.
[26] T. Lister,et al. Mutation of CEBPA in familial acute myeloid leukemia. , 2004, The New England journal of medicine.
[27] T. Vulliamy,et al. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC , 2004, Nature Genetics.
[28] S. Chanock,et al. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. , 2003, Blood.
[29] K. Collins,et al. Distinct biogenesis pathways for human telomerase RNA and H/ACA small nucleolar RNAs. , 2003, Molecular cell.
[30] Jiunn-Liang Chen,et al. A critical stem-loop structure in the CR4-CR5 domain of mammalian telomerase RNA. , 2002, Nucleic acids research.
[31] T. Vulliamy,et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita , 2001, Nature.
[32] I. Dokal,et al. Dyskeratosis congenita in all its forms , 2000, British journal of haematology.
[33] John M. Maris,et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.
[34] J. Shay,et al. A survey of telomerase activity in human cancer. , 1997, European journal of cancer.
[35] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[36] C B Harley,et al. Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[37] C. Harley,et al. Telomeres shorten during ageing of human fibroblasts , 1990, Nature.
[38] Carol W. Greider,et al. Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.
[39] I. Baumann,et al. TERC mutations in children with refractory cytopenia. , 2006, Haematologica.